Edward J Collins

Title: Edward J Collins: Innovator in Immunogenic Peptides

Introduction

Edward J Collins is a notable inventor based in Carrboro, NC (US). He has made significant contributions to the field of immunology, particularly through his work on immunogenic peptides derived from the HPV E7 protein. With a total of 4 patents, Collins has established himself as a key figure in the development of innovative medical solutions.

Latest Patents

Collins' latest patents focus on immunogenic peptides from the HPV type 16 E7 protein. These inventions provide overlapping class I restricted T cell epitopes, which are crucial for developing effective vaccines and therapies. Additionally, the patents disclose methods for administering DNA molecules encoding these peptides to a host mammal, further enhancing their potential applications in immunotherapy.

Career Highlights

Throughout his career, Collins has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Zycos Inc. and MGI Pharma Biologics, Inc. His work in these organizations has contributed to advancements in biologics and therapeutic development.

Collaborations

Collins has collaborated with esteemed colleagues, including Robert G Urban and Roman M Chicz. These partnerships have fostered a collaborative environment that has led to innovative breakthroughs in their respective fields.

Conclusion

Edward J Collins is a distinguished inventor whose work on immunogenic peptides has the potential to impact the field of immunology significantly. His contributions, along with his collaborations, highlight the importance of innovation in developing effective medical treatments.